VoltaXplore Inc., Martinrea International Inc., and NanoXplore Inc. to Host Battery Day on April 5

As previously announced, VoltaXplore Inc., a 5050 joint venture between Martinrea International Inc. (TSX : MRE) and NanoXplore Inc. (TSX : GRA) aimed at commercializing the production of graphene-enhanced lithium-ion batteries for the electric vehicle and other potential markets, will host Battery Day later today at its demonstration facility, located in Montreal, Quebec.

Battery Day will consist of a tour of the demonstration facility, as well as presentations and technical discussions by VoltaXplore representatives including senior management. There will be multiple sessions taking place throughout the day. A copy of the presentation has been posted at www.voltaxplore.com , www.martinrea.com , and www.nanoxplore.ca .

VoltaXplore commissioned its one megawatt-hour demonstration facility in early March. The facility is producing batteries which are currently being optimized. Testing conducted by third parties to date, as well as internal testing confirms the advantages of using graphene in Li-Ion battery production, including greater battery capacity, battery life, and charging speed, as well as enhanced safety.

"VoltaXplore is making great progress and is on track toward meeting its expected milestones and timelines," said Pat D'Eramo, Chairman of VoltaXplore and President and Chief Executive Officer of Martinrea. "We remain excited about the venture, as we believe graphene-enhanced batteries are a differentiated technology that could go a long way toward addressing concerns around range and safety currently preventing more wide-scale adoption of electric vehicles. Our testing to date supports this."

"We are excited about the prospect of being part of an integrated supply chain of Li-Ion batteries and related materials in North America, as well as a made-in-Canada solution for high-performance batteries that enhance driving range, battery life, charging speed, and safety" said Soroush Nazarpour, Chief Executive Officer of VoltaXplore and President and Chief Executive Officer of NanoXplore. "With our demonstration facility up and running, and our technology validated, we are now focused on the next steps to bring the project to fruition."

About VoltaXplore Inc.

VoltaXplore is a 50/50 joint venture between Martinrea International Inc. and NanoXplore Inc. aimed at commercializing and developing graphene-enhanced lithium-ion batteries for the electric vehicle market. VoltaXplore was established on April 15, 2021. Please visit www.voltaxplore.com .

About Martinrea International Inc.

Martinrea is a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered, value-added Lightweight Structures and Propulsion Systems. Martinrea operates in 57 locations in Canada, the United States, Mexico, Brazil, Germany, Slovakia, Spain, China, South Africa and Japan. Martinrea's vision is making lives better by being the best supplier we can be in the products we make and the services we provide. For more information on Martinrea, please visit www.martinrea.com . Follow Martinrea on Twitter and Facebook .

About NanoXplore Inc.

NanoXplore is a graphene company, a manufacturer and supplier of high-volume graphene powder for use in transportation and industrial markets. The Company provides standard and custom graphene-enhanced plastic and composite products to various customers in transportation, packaging, electronics, and other industrial sectors. NanoXplore is headquartered in Montreal, Quebec with manufacturing facilities across North America and Europe. Please visit www.nanoxplore.ca .

FORWARD-LOOKING INFORMATION

Special Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable Canadian securities laws including statements and expectations related to expectations of the benefit of graphene to battery production and expansion to a larger gigawatt facility. The words "continue", "expect", "anticipate", "estimate", "may", "will", "should", "views", "intend", "believe", "plan", "outlook" and similar expressions are intended to identify forward-looking statements. Forward-looking statements are based on estimates and assumptions made by VoltaXplore, Martinrea and NanoXplore in light of their experience and their perception of historical trends, current conditions and expected future developments, as well as other factors that they believe are appropriate in the circumstances, such as expected sales and industry production estimates, current foreign exchange rates (FX), timing of product launches and operational improvements during the period and any current Board approved budgets. Many factors could cause actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the industry trends and risk factors outlined in the most recent Management Discussion and Analysis and Annual Information Form and other public filings for each of Martinrea and NanoXplore which can be found at www.sedar.com .

These factors should be considered carefully, and readers should not place undue reliance on the forward-looking statements. VoltaXplore, Martinrea and NanoXplore has no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

The common shares of Martinrea trade on The Toronto Stock Exchange under the symbol "MRE". The common shares of NanoXplore trade on The Toronto Stock Exchange under the symbol "GRA".

For further information, please contact:

Soroush Nazarpour
President and CEO, NanoXplore Inc.
CEO, VoltaXplore Inc.
info@nanoxplore.ca
Tel: 514.935.1377

INVESTOR RELATIONS:
Neil Forster, Director, Investor Relations and Corporate Development
Martinrea International Inc.
neil.forster@martinrea.com
Mobile: 647.210.2385

MEDIA CONTACT:
Deanna Lorincz, Global Director, Communications and Marketing
Martinrea International Inc.
deanna.lorincz@martinrea.com
Tel: 248.392.9727
Mobile: 586.634.1766


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

GRA:CA,NNXPF
The Conversation (0)
Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Determined maximum tolerated dose (MTD) in Phase 1 monotherapy study of NUV-868; Phase 1b studies of NUV-868 in combination with olaparib or enzalutamide remain ongoing

Received U.S. Food and Drug Administration (FDA) clearance of Investigational New Drug (IND) application for NUV-1511, the first clinical candidate from our novel drug-drug conjugate (DDC) platform

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors

Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors

Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, today announced the appointment of Robert Mashal, M.D. to its Board of Directors.

"We are delighted to have Dr. Mashal join our Board of Directors," said David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio. "Robert is a seasoned biotech industry veteran and his experience as an investor, operator, and medical oncologist will provide us with valuable insights. We look forward to working with Robert to advance Nuvation's pipeline."

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors

NUV-1511 is the first clinical candidate from the company's novel drug-drug conjugate platform

Company anticipates initiating a Phase 1/2 clinical study of NUV-1511 in 1H 2024

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

NanoXplore Receives TSX Approval for Normal Course Issuer Bid

NanoXplore Inc. (TSX: GRA) ("NanoXplore" or the "Corporation") is pleased to announce that the Toronto Stock Exchange (TSX) has approved the Corporation's request to adopt a normal course issuer bid (NCIB) program, through which NanoXplore may purchase, for cancellation, up to 5,936,205 common shares or approximately 5% of the public float (consisting of 118,724,119 common shares as of November 22, 2023, out of the 169,378,431 common shares issued and outstanding). The Corporation may purchase shares under the NCIB over a period of twelve months commencing on December 1, 2023 and ending November 30, 2024, when the bid expires. NCIB purchases are through the facilities of the TSX and certain Canadian Alternative Trading Systems and the price for any repurchased shares will be the prevailing market price at the time of the acquisition.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

NanoXplore Unveils a Large-Scale Dry Process for Manufacturing of Graphene: An Improvement for Cost Competitiveness and Scalability

NanoXplore Inc. ("NanoXplore" or "the Corporation") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, proudly announces an interesting achievement in graphite exfoliation with the successful development of a novel dry graphene manufacturing process.

The dry process centers on an advanced exfoliation technology with innovative media that enables high yield exfoliation without the introduction of impurities.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

NanoXplore Reports Results for its Q1-2024

NanoXplore Inc. ("NanoXplore" or "the Corporation") (TSX: GRA and OTCQX: NNXPF), a world-leading graphene company, reported today financial results for the three-month period ended September 30, 2023.

All amounts in this press release are in Canadian dollars, unless otherwise stated.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×